Iopanoic	O
acid	O
is	O
an	O
iodine-containing	O
radiocontrast	O
medium	O
used	O
incholecystography	O
.	O
Both	O
iopanoic	O
acid	O
and	O
ipodate	O
sodium	O
are	O
potent	O
inhibitorsof	O
thyroid	O
hormone	O
release	O
from	O
thyroid	O
gland	O
,	O
as	O
well	O
as	O
of	O
peripheralconversion	O
of	O
thyroxine	O
to	O
triiodothyronine	O
.	O
These	O
compoundsinhibit	O
5	NUMBER
`	O
deiodinase	O
-LRB-	O
5	NUMBER
`	O
DID-1	O
and	O
5	NUMBER
`	O
DID-2	O
-RRB-	O
enzymes	O
,	O
which	O
catalyse	O
T4-T3conversion	O
in	O
the	O
thyroid	O
cell	O
,	O
liver	O
,	O
kidney	O
,	O
skeletal	O
muscle	O
,	O
heart	O
,	O
brain	O
,	O
pituitary	O
.	O
This	O
accounts	O
for	O
the	O
dramatic	O
improvement	O
in	O
both	O
subjective	O
andobjective	O
symptoms	O
of	O
hyperthyroidism	O
,	O
particularly	O
when	O
they	O
are	O
used	O
as	O
anadjunctive	O
therapy	O
with	O
thioamides	O
.	O
They	O
canbe	O
used	O
in	O
the	O
treatment	O
of	O
patients	O
with	O
severe	O
thyrotoxicosis	O
-LRB-	O
thyroidstorm	O
-RRB-	O
and	O
significant	O
morbidity	O
forrapid	O
control	O
of	O
elevated	O
plasma	O
triiodothyronine	O
concentrations	O
.	O
The	O
use	O
ofiopanoic	O
acid	O
for	O
treatment	O
of	O
thyrotoxicosis	O
has	O
been	O
discontinued	O
in	O
theUnited	LOCATION
States	LOCATION
.	O
